Novan, Inc.
NASDAQ: NOVN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Paula Brown Stafford
- Employees
- 90
- Headquarters
- Durham, United States
- IPO year
- 2016
- Market cap
- $2.6M
- Website
- https://www.novan.com
Loading NOVN…
Loading profile data…Frequently asked questions about NOVN
What does Novan, Inc. (NOVN) do?
Novan, Inc. operates as a pre-commercial pharmaceutical entity specializing in nitric oxide-derived therapies for dermatological and anti-infective conditions. The company boasts a robust clinical-stage pipeline featuring several topical drug candidates. For skin-related ailments, these include SB204, a monotherapy aimed at acne vulgaris; SB206,...
Where does NOVN trade?
Novan, Inc. (NOVN) trades on the NASDAQ Capital Market.
What sector is NOVN in?
Novan, Inc. (NOVN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Novan, Inc.?
Paula Brown Stafford is the chief executive officer of Novan, Inc. (NOVN).
Where is Novan, Inc. headquartered?
Novan, Inc. is headquartered in United States.
Does NOVN pay a dividend?
Novan, Inc. (NOVN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NOVN go public?
Novan, Inc. (NOVN) completed its initial public offering in 2016.